Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment

Epstein-Barr virus (EBV) is a pathogen that infects more than 90% of global human population. EBV primarily targets B-lymphocytes and epithelial cells while some of them infect monocyte/macrophage, T-lymphocytes, and dendritic cells (DCs). EBV infection does not cause death by itself but the infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Teow, Sin-Yeang, Yap, Hooi-Yeen, Peh, Suat-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804410/
https://www.ncbi.nlm.nih.gov/pubmed/29464124
http://dx.doi.org/10.1155/2017/7349268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804410/
https://www.ncbi.nlm.nih.gov/pubmed/29464124
http://dx.doi.org/10.1155/2017/7349268

Ejemplares similares